SDCL § 58-17H-56: Limitations.
Where this section sits in the code
- TITLE 58. INSURANCE
- CHAPTER 58-17H. UTILIZATION REVIEW AND BENEFIT DETERMINATIONS
Nothing in §§ 58-17H-53 to 55-17H-56 shall be construed to prevent:
(1)A health carrier, health benefit plan, or utilization review organization from requiring a covered person to try a prescription drug with the same generic name and demonstrated bioavailability or biological product that is an interchangeable biological product pursuant to §§ 36-11-46.1 and 36-11-46.9 before providing coverage for the equivalent branded prescription drug;
(2)A health care professional from prescribing a prescription drug that is determined to be medically appropriate.
Collected 2026-09-03T15:18:57Z. Source file · JSON